What is the recommended dosage and treatment duration of Terbinafine (antifungal medication) for fungal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Terbinafine Dosage and Treatment Duration for Fungal Infections

For fungal nail infections (onychomycosis), terbinafine should be administered at 250 mg once daily for 6 weeks for fingernails and 12 weeks for toenails, as this regimen provides the highest cure rates with minimal side effects. 1

Recommended Dosages by Infection Type

Onychomycosis (Nail Infections)

  • Fingernail infections: 250 mg once daily for 6 weeks 1
  • Toenail infections: 250 mg once daily for 12 weeks 1
  • Mycological cure rates range from 73-94% for toenails 2
  • Clinical studies show 82% mycological cure for toenail infections after 12 weeks of treatment 3

Tinea Capitis (Scalp Ringworm)

  • Weight-based dosing 2:
    • <20 kg: 62.5 mg daily for 2-4 weeks
    • 20-40 kg: 125 mg daily for 2-4 weeks
    • 40 kg: 250 mg daily for 2-4 weeks

  • More effective against Trichophyton species than Microsporum species 2

Other Dermatophyte Infections

  • Tinea corporis/cruris: 250 mg once daily for 2-4 weeks 4
  • Tinea pedis: 250 mg once daily for 2-4 weeks 4

Administration Considerations

  • Can be taken with or without food 1
  • If a dose is missed, take as soon as remembered unless less than 4 hours before next dose 1
  • Terbinafine is highly lipophilic and keratophilic, allowing it to persist in nails, skin, and hair for months after treatment cessation 5

Alternative Dosing Regimens

Some studies have explored pulse therapy options:

  • Weekly intermittent dosing: 500 mg/day for 1 week per month for 4 months 5
  • Single-dose: 1000 mg per month for 4 months 5
  • A comparative study showed that pulsed dosing (500 mg/day for 1 week every 4 weeks over 16 weeks) achieved similar mycological cure rates to continuous dosing (250 mg/day for 16 weeks) 6

Mechanism of Action and Efficacy

Terbinafine is an allylamine antifungal that:

  • Inhibits squalene epoxidase, blocking ergosterol synthesis in the fungal cell wall 7
  • Has fungicidal activity against dermatophytes, with very low minimum inhibitory concentration (0.004 μg/mL) 7
  • Is more effective than itraconazole and griseofulvin for dermatophyte infections 7, 4
  • Achieves mycological cure in >80% of patients with superficial dermatophyte infections 4

Safety and Monitoring

  • Baseline liver function tests are recommended before starting treatment 2
  • Common side effects include headache, diarrhea, rash, dyspepsia, liver enzyme abnormalities, and taste disturbance 1
  • Serious but rare side effects include liver failure, severe taste/smell disturbance, depressive symptoms, and severe skin reactions 1
  • Contraindicated in patients with history of allergic reaction to oral terbinafine 1

Drug Interactions

  • Terbinafine inhibits CYP2D6 and may affect metabolism of:
    • Desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine 1
    • Plasma concentrations reduced by rifampicin, increased by cimetidine 7

Special Populations

  • Children: Terbinafine is effective and safe for tinea capitis and onychomycosis in children, with weight-based dosing 8
  • Hepatic impairment: Avoid in severe hepatic disease 2
  • Pregnancy: Not recommended without consulting physician 1

Treatment Failure Considerations

If treatment fails, consider:

  • Poor compliance
  • Poor absorption
  • Relative insensitivity of the organism
  • Reinfection 2

Terbinafine's fungicidal mechanism of action and residual effect in tissue often lead to improved mycological cure rates even after treatment cessation 4.

References

Guideline

Treatment of Dermatophyte Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Update on antifungal therapy with terbinafine.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.